NIAID Banner Logo Image


1. 61222 OI-LS-378; EMBASE-OI-7/9/2007

Antibacterial and antimycobacterial activities of South African Salvia species and isolated compounds from S. chamelaeagnea

Kamatou, GPP, Van Vuuren, SF, Van Heerden, FR, Seaman, T, and Viljoen, AM

South African Journal of Botany 2007. In Press, Corrected Proof: 372


2. 61223 OI-LS-378; EMBASE-OI-7/9/2007

Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives

Karali, Nilgun, Gursoy, Aysel, Kandemirli, Fatma, Shvets, Nathaly, Kaynak, FBetul, Ozbey, Suheyla, Kovalishyn, Vasyl, and Dimoglo, Anatholy

Bioorganic & Medicinal Chemistry 2007. In Press, Corrected Proof: 3316


3. 61224 OI-LS-378; WOS-OI-6/29/2007

Cryptosporidium Parvum: Identification and Characterization of an Acid Phosphatase

Aguirre-Garcia, M. and Okhuysen, P.

Parasitology Research 2007. 101(1): 85-89


4. 61225 OI-LS-378; EMBASE-OI-7/9/2007

In search of cyclooxygenase inhibitors, anti-Mycobacterium tuberculosis and anti-malarial drugs from Thai flora and microbes

Gale, George A, Kirtikara, Kanyawim, Pittayakhajonwut, Pattama, Sivichai, Somsak, Thebtaranonth, Yodhathai, Thongpanchang, Chawanee, and Vichai, Vanicha

Pharmacology & Therapeutics 2007. In Press, Accepted Manuscript: 746


5. 61226 OI-LS-378; EMBASE-OI-7/9/2007

Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli [beta]-ketoacyl-ACP-synthase III (FabH)

Alhamadsheh, Mamoun M, Waters, Norman C, Huddler, Donald P, Kreishman-Deitrick, Mara, Florova, Galina, and Reynolds, Kevin A

Bioorganic & Medicinal Chemistry Letters 2007. 17(4): 879-883


6. 61227 OI-LS-378; WOS-OI-6/29/2007

New Rifamycins for the Treatment of Bacterial Infections

Combrink, K. and Lynch, A.

Expert Opinion on Therapeutic Patents 2007. 17(5): 475-485


7. 61228 OI-LS-378; WOS-OI-6/29/2007

Nucleoside Natural Products and Related Analogs With Potential Therapeutic Properties as Antibacterial and Antiviral Agents

Ichikawa, S. and Matsuda, A.

Expert Opinion on Therapeutic Patents 2007. 17(5): 487-498


8. 61229 OI-LS-378; EMBASE-OI-7/9/2007

Antifungal dibenzofuran bis(bibenzyl)s from the liverwort Asterella angusta: Reports on Structure Elucidation

Qu, Jianbo, Xie, Chunfeng, Guo, Huaifang, Yu, Wentao, and Lou, Hongxiang

Phytochemistry 2007. 68(13): 1767-1774


9. 61230 OI-LS-378; EMBASE-OI-7/9/2007

The antifungal activity of twenty-four southern African Combretum species (Combretaceae)

Masoko, P, Picard, J, and Eloff, JN

South African Journal of Botany 2007. 73(2): 173-183


10. 61231 OI-LS-378; WOS-OI-6/29/2007

Inhibition of Mycobacterial Arylamine N-Acetyltransferase Contributes to Anti-Mycobacterial Activity of Warburgia Salutaris

Madikane, V. et al.

Bioorganic & Medicinal Chemistry 2007. 15(10): 3579-3586


11. 61232 OI-LS-378; EMBASE-OI-7/9/2007

Hazel (Corylus avellana L.) leaves as source of antimicrobial and antioxidative compounds

Oliveira, Ivo, Sousa, Anabela, Valentao, Patricia, Andrade, Paula B, Ferreira, Isabel CFR, Ferreres, Federico, Bento, Albino, Seabra, Rosa, Estevinho, Leticia, and Pereira, Jose Alberto

Food Chemistry 2007. In Press, Corrected Proof: 3853


12. 61233 OI-LS-378; EMBASE-OI-7/9/2007

Development of Carboxylic Acid Replacements in Indole-N Acetamide Inhibitors of Hepatitis C Virus NS5B Polymerase

Stansfield, Ian, Pompei, Marco, Conte, Immacolata, Ercolani, Caterina, Migliaccio, Giovanni, Jairaj, Mark, Giuliano, Claudio, Rowley, Michael, and Narjes, Frank

Bioorganic & Medicinal Chemistry Letters 2007. In Press, Accepted Manuscript: 9


13. 61234 OI-LS-378; EMBASE-OI-7/9/2007

Interferon-based treatment of chronic hepatitis C: Interferons - 1957-2007 - Interferons: from discovery to mechanism of action and clinical applications

Souvignet, Claude, Lejeune, Olivier, and Trepo, Christian

Biochimie 2007. 89(6-7): 894-898


14. 61235 OI-LS-378; EMBASE-OI-7/9/2007

Inhibition of an Innate Antiviral Response by Human Cytomegalovirus UL97 Kinase is Antagonized by Maribavir

Prichard, Mark, Daily, Shannon, Perry, Amie, Hartline, Caroll, and Kern, Earl

Antiviral Research 2007. 74(3): A41-A42


15. 61236 OI-LS-378; WOS-OI-7/6/2007

Hepatitis C Virus Proteins

Dubuisson, J.

World Journal of Gastroenterology 2007. 13(17): 2406-2415


16. 61237 OI-LS-378; WOS-OI-7/6/2007

Cell Culture Systems for the Hepatitis C Virus

Duverlie, G. and Wychowski, C.

World Journal of Gastroenterology 2007. 13(17): 2442-2445


17. 61238 OI-LS-378; WOS-OI-7/6/2007

A Computational Model of the Inhibition of Mycobacterium Tuberculosis Atpase by a New Drug Candidate R207910

De Jonge, M. et al.

Proteins-Structure Function and Bioinformatics 2007. 67(4 ): 971-980


18. 61239 OI-LS-378; WOS-OI-7/6/2007

Antimycobacterial Activity of Lichens

Gupta, V. et al.

Pharmaceutical Biology 2007. 45(3): 200-204


19. 61240 OI-LS-378; WOS-OI-7/6/2007

Synthesis and Studies of Catechol-Containing Mycobactin S and T Analogs

Walz, A., Mollmann, U., and Miller, M.

Organic & Biomolecular Chemistry 2007. 5(10): 1621-1628


20. 61241 OI-LS-378; WOS-OI-7/6/2007

Inhibition of Intracellular Hepatitis C Virus Replication by the Pkr Pathway

Chang, J. et al.

Journal of Gastroenterology and Hepatology 2006. 21: A20


21. 61242 OI-LS-378; WOS-OI-7/6/2007

Interferon-Beta Is Activated by Hepatitis C Virus Ns5b and Inhibited by Ns4a, Ns4b, and Ns5a

Moriyama, M., Kato, N., and Otsuka, M.

Journal of Gastroenterology and Hepatology 2006. 21: A21


22. 61243 OI-LS-378; WOS-OI-7/6/2007

The Interferon Inducing Pathways and the Hepatitis C Virus

Meurs, E. and Breiman, A.

World Journal of Gastroenterology 2007. 13(17): 2446-2454


23. 61244 OI-LS-378; WOS-OI-7/6/2007

Bone Morphogenetic Protein-7 and Interferon-Alpha Synergistically Suppress Hepatitis C Virus Replicon

Sakamoto, N. et al.

Biochemical and Biophysical Research Communications 2007. 357(2): 467-473


24. 61245 OI-LS-378; WOS-OI-7/6/2007

Flying Under the Radar: the Immunobiology of Hepatitis C

Dustin, L. and Rice, C.

Annual Review of Immunology 2007. 25: 71-99


25. 61246 OI-LS-378; PUBMED-OI-7/9/2007

Biocidal effect of bleach on Mycobacterium tuberculosis: a safety measure

Githui, WA, Matu, SW, Tunge, N, and Juma, E

Int J Tuberc Lung Dis 2007. 11(7): 798-802


26. 61247 OI-LS-378; PUBMED-OI-7/9/2007

[1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains

Carta, A, Palomba, M, Paglietti, G, Molicotti, P, Paglietti, B, Cannas, S, and Zanetti, S

Bioorg Med Chem Lett 2007.


27. 61248 OI-LS-378; PUBMED-OI-7/9/2007

Antimicrobial resistance prevention initiative--an update: proceedings of an expert panel on resistance

Moellering, RC Jr, Graybill, JR, McGowan, JE Jr, and Corey, L

Am J Med 2007. 120(7): S4-25; quiz S26-8


28. 61249 OI-LS-378; PUBMED-OI-7/9/2007

Growth Inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium In Vitro: Effect of 1-beta-d-2'-Arabinofuranosyl and 1-(2'-Deoxy-2'-fluoro-beta-d-2'-ribofuranosyl) Pyrimidine Nucleoside Analogs

Johar, M, Manning, T, Tse, C, Desroches, N, Agrawal, B, Kunimoto, DY, and Kumar, R

J Med Chem 2007.


29. 61250 OI-LS-378; PUBMED-OI-7/9/2007

Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis

Kruh, NA, Rawat, R, Ruzsicska, BP, and Tonge, PJ

Protein Sci 2007.


30. 61251 OI-LS-378; PUBMED-OI-7/9/2007

Ribavirin Up-Regulates the Activity of Double-Stranded RNA-Activated Protein Kinase and Enhances the Action of Interferon- alpha against Hepatitis C Virus

Liu, WL, Su, WC, Cheng, CW, Hwang, LH, Wang, CC, Chen, HL, Chen, DS, and Lai, MY

J Infect Dis 2007. 196(3): 425-34


31. 61252 OI-LS-378; PUBMED-OI-7/9/2007

High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: Insights into the mechanism and specificity of this novel prokaryotic enzyme

Reddy, MC, Palaninathan, SK, Shetty, ND, Owen, JL, Watson, MD, and Sacchettini, JC

J Biol Chem 2007.


32. 61253 OI-LS-378; PUBMED-OI-7/9/2007

Functional characterization by genetic complementation of aroB-encoded dehydroquinate synthase from Mycobacterium tuberculosis H37Rv and its heterologous expression and purification

de Mendonca, JD, Ely, F, Palma, MS, Frazzon, J, Basso, LA, and Santos, DS

J Bacteriol 2007.


33. 61254 OI-LS-378; PUBMED-OI-7/9/2007

Synthesis and chemical characterisation of target identification reagents based on an inhibitor of human cell invasion by the parasite Toxoplasma gondii

Evans, KM, Haraldsen, JD, Pearson, RJ, Slawin, AM, Ward, GE, and Westwood, NJ

Org Biomol Chem 2007. 5(13): 2063-9


34. 61255 OI-LS-378; PUBMED-OI-7/9/2007

LspA-independent action of globomycin on Mycobacterium tuberculosis

Banaiee, N, Jacobs, WR, and Ernst, JD

J Antimicrob Chemother 2007.


35. 61256 OI-LS-378; PUBMED-OI-7/9/2007

Cation induced differential effect on structural and functional properties of Mycobacterium tuberculosis alpha-isopropylmalate synthase

Singh, K and Bhakuni, V

BMC Struct Biol 2007. 7(1): 39


36. 61257 OI-LS-378; PUBMED-OI-7/9/2007

Host factors involved in the replication of hepatitis C virus

Moriishi, K and Matsuura, Y

Rev Med Virol 2007.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024